News / New publications

Research

We work together for a better translational approach, from basic to clinical science

  • Read more

Core facilities

Our advanced core facilities offer excellent opportunities

  • Read more

Recruitment

We welcome the best research talents from Norway and the rest of the world

  • Read more

Archives IEMR

  • Publications
  • News archive
  • Visual profile

About IEMR

  • About
  • Funding
  • Collaborations
  • Staff

Contact IEMR

  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)

How does protection against oxidative stress prevent arrhythmias?

The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1

Mani Sadredini, Ravinea Manotheepan, Stephan E. Lehnart, Mark E. Anderson, Ivar Sjaastad and Mathis Korseberg Stokke

Oxidation of molecules in cardiac cells contributes to the development of arrhythmias, but oral antioxidants have failed to protect against arrhythmias in clinical trials. Targeted prevention of oxidation at specific molecular sites may be more efficient. Protection from oxidation of the cardiac enzyme calcium/calmodulin-dependent protein kinase II (CaMKII) has been suggested as an antiarrhythmic strategy. In a follow-up of a previous publication (Manotheepan et al. 2016, PMID: 27161030) PhD student Mani Sadredini and the Stokke group collaborated with Professor Stephan Lehnart from the University of Göttingen (Germany) and Professor Mark E. Anderson from the Johns Hopkins University, to combine mice with the inherited arrhythmia syndrome catecholaminergic polymorphic ventricular tachycardia (CPVT) with mice genetically protected against oxidation of CaMKII. While global reduction of oxidative stress from the strong antioxidant N-acetyl cysteine reduced arrhythmia-associated behavior in CPVT cells, specific protection against CaMKII did not. Other oxidation sensitive targets should be investigated to understand the role of oxidation in arrhythmias and the antiarrhythmic potential of antioxidants.

 

Read the article in Physiological Reports

 

doi: 10.14814/phy2.15030

Mani Sadredini

Postdoctoral fellow

  • View profile

Mathis Korseberg Stokke

Head of Department & Group Leader & Professor & Senior Consultant

  • View profile

Institute for Experimental Medical Research

Oslo University Hospital, Ullevål

PB 4956 Nydalen

NO-0424 Oslo

Norway

  • Research
  • Core facilities
  • Recruitment
  • Publications
  • News archive
  • Visual profile
  • About
  • Funding
  • Collaborations
  • Staff
  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)